Bioxytran (BIXT) 8-K Entry into a Material Definitive Agreement

EXHIBIT A

U.S. RARE EARTH MINERALS, INC.

BALANCE SHEETS

(UNAUDITED)

	November 20,			December 31,
	2017			2016
ASSETS
CURRENT ASSETS:
Cash	$	22,662		$	11,092
Accounts Receivable		44,379			9,600
Inventory		5,481			6,272
Total current assets	$	72,522		$	26,964
Property and Equipment, Net of Accumulated Depreciation of $275,161 and $266,366 respectively		686,535			24,707
TOTAL ASSETS	$	759,057		$	51,671
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES:
Accounts payable and accrued expenses	$	7,568		$	37,165
Accounts payable – related party		-			168,325
10% Series A Senior (non-subordinated) debentures		5,000			5,000
Loans payable		25,000			25,000
Notes payable		80,000			80,000
Accrued interest		27,676			26,776
Total current liabilities		145,194			342,266
Total liabilities		145,194			342,266
STOCKHOLDERS' DEFICIT:
Preferred stock: $0.001 par value; 50,000,000 authorized, 440,500 shares issued and outstanding as of June 30, 2017 and December 31, 2016		441			441
Common stock: $0.001 par value; 300,000,000 authorized, 105,416,350 and 28,166,350 shares issued and outstanding as of  November 20, 2017 and December 31, 2016 respectively		105,416			28,166
Additional paid in capital		14,637,719			13,563,598
Accumulated deficit		(14,129,713	)		(13,882,800	)
Total stockholders' deficit		613,863			(290,595	)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	759,057		$	51,671